Literature DB >> 2898972

Alcohol, barbiturate and benzodiazepine withdrawal syndromes: clinical management.

E M Sellers1.   

Abstract

The symptoms and clinical management of alcohol, barbiturate and benzodiazepine withdrawal syndromes are discussed in this article. People who suffer alcohol withdrawal should be admitted to hospital if they have medical or surgical complications or severe symptoms; supportive care and pharmacotherapy, especially diazepam loading, are the essential components of treatment. Barbiturate withdrawal requires pharmacotherapy and admission to hospital for patients who have taken more than 0.4 g/d of secobarbital or an equivalent amount of another barbiturate for 90 days or longer, or 0.6 g/d or an equivalent dose for 30 days or longer, or who have had withdrawal seizures or delirium; phenobarbital loading is recommended. Regular benzodiazepine therapy that has lasted at least 3 months should be gradually stopped. Short-acting agents should be replaced with long-acting ones, such as diazepam, to avoid withdrawal symptoms. Most of these patients can be managed on an outpatient basis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2898972      PMCID: PMC1268024     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  20 in total

1.  Withdrawal reaction after long-term therapeutic use of benzodiazepines.

Authors:  U Busto; E M Sellers; C A Naranjo; H Cappell; M Sanchez-Craig; K Sykora
Journal:  N Engl J Med       Date:  1986-10-02       Impact factor: 91.245

2.  Treatment of the barbiturate abstinence syndrome.

Authors:  J T Sullivan; E M Sellers
Journal:  Med J Aust       Date:  1986-11-03       Impact factor: 7.738

3.  Treatment of the acute alcohol withdrawal state: a comparison of four drugs.

Authors:  S C Kaim; C J Klett; B Rothfeld
Journal:  Am J Psychiatry       Date:  1969-06       Impact factor: 18.112

4.  Gradual withdrawal of diazepam after long-term therapy.

Authors:  P Tyrer; R Owen; S Dawling
Journal:  Lancet       Date:  1983-06-25       Impact factor: 79.321

5.  Treating alcohol, barbiturate, and benzodiazepine withdrawal.

Authors:  J T Sullivan; E M Seller
Journal:  Ration Drug Ther       Date:  1986-02

6.  Diagnosis and management of depressant drug dependence.

Authors:  J A Ewing; W E Bakewell
Journal:  Am J Psychiatry       Date:  1967-02       Impact factor: 18.112

7.  Withdrawal from long-term benzodiazepine treatment.

Authors:  H Petursson; M H Lader
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-05

8.  Prevention of alcohol withdrawal seizures with oral diazepam loading.

Authors:  P Devenyi; M L Harrison
Journal:  Can Med Assoc J       Date:  1985-04-01       Impact factor: 8.262

9.  Diazepam tapering in detoxification for high-dose benzodiazepine abuse.

Authors:  M Harrison; U Busto; C A Naranjo; H L Kaplan; E M Sellers
Journal:  Clin Pharmacol Ther       Date:  1984-10       Impact factor: 6.875

10.  Effect of short- and long-term alcohol use on phenytoin kinetics in chronic alcoholics.

Authors:  P Sandor; E M Sellers; M Dumbrell; V Khouw
Journal:  Clin Pharmacol Ther       Date:  1981-09       Impact factor: 6.875

View more
  12 in total

1.  Another perspective on management of withdrawal.

Authors:  D Bates
Journal:  Can Fam Physician       Date:  1997-03       Impact factor: 3.275

Review 2.  Drug deprescription-withdrawal risk, prevention, and treatment.

Authors:  Madison K Bangert; Gabriel M Aisenberg
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-12-20

3.  Diagnosis and management of acute alcohol withdrawal.

Authors:  A M Holbrook; R Crowther; A Lotter; C Cheng; D King
Journal:  CMAJ       Date:  1999-03-09       Impact factor: 8.262

4.  Meta-analysis of benzodiazepine use in the treatment of acute alcohol withdrawal.

Authors:  A M Holbrook; R Crowther; A Lotter; C Cheng; D King
Journal:  CMAJ       Date:  1999-03-09       Impact factor: 8.262

Review 5.  Giant cell arteritis (temporal arteritis) affecting the breast: report of two cases and review of published reports.

Authors:  R J McKendry; M Guindi; D P Hill
Journal:  Ann Rheum Dis       Date:  1990-12       Impact factor: 19.103

Review 6.  Manipulation of GABAergic steroids: Sex differences in the effects on alcohol drinking- and withdrawal-related behaviors.

Authors:  Deborah A Finn; Ethan H Beckley; Katherine R Kaufman; Matthew M Ford
Journal:  Horm Behav       Date:  2009-07-15       Impact factor: 3.587

7.  Risk factors for delirium tremens development.

Authors:  J A Ferguson; C J Suelzer; G J Eckert; X H Zhou; R S Dittus
Journal:  J Gen Intern Med       Date:  1996-07       Impact factor: 5.128

8.  Diazepam dependence prevented by glutamate antagonists.

Authors:  K G Steppuhn; L Turski
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

9.  Hyperalgesia after a Drinking Episode in Young Adult Binge Drinkers: A Cross-Sectional Study.

Authors:  Dokyoung S You; Hunter A Hahn; Thomas H Welsh; Mary W Meagher
Journal:  Alcohol Alcohol       Date:  2020-10-20       Impact factor: 2.826

10.  The Experience Elicited by Hallucinogens Presents the Highest Similarity to Dreaming within a Large Database of Psychoactive Substance Reports.

Authors:  Camila Sanz; Federico Zamberlan; Earth Erowid; Fire Erowid; Enzo Tagliazucchi
Journal:  Front Neurosci       Date:  2018-01-22       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.